Secretion, migration and adhesion as key processes in the therapeutic activity of mesenchymal stem cells. Kot M, Musiał-Wysocka A, Lasota M, Ulman A, Majka M. Acta Biochim Pol. 2019 Dec 28;66(4):499-507. doi: 10.18388/abp.2019_2895. 

Molecular mechanisms of epithelial to mesenchymal transition in tumor metastasis. Nieszporek A, Skrzypek K, Adamek G, Majka M. Acta Biochim Pol. 2019 Dec 28;66(4):509-520. doi: 10.18388/abp.2019_2899.

The Importance of HLA Assessment in „Off-the-Shelf” Allogeneic Mesenchymal Stem Cells Based-Therapies. Kot M, Baj-Krzyworzeka M, Szatanek R, Musiał-Wysocka A, Suda-Szczurek M, Majka M. Int J Mol Sci. 2019 Nov 13;20(22). pii: E5680. doi: 10.3390/ijms20225680.

Microwave-assisted synthesis and characterization of novel chitosan-based biomaterials for pelvic organ prolapse treatment. Stangel-Wojcikiewicz K, Piatkowski M, Radwan-Praglowska J, Janus L, Matysek D, Majka M, Kot M, Amrom D, Wrobel A. J Physiol Pharmacol. 2019 Jun;70(3). doi: 10.26402/jpp.2019.3.15. Epub 2019 Sep 27.

Regenerative potential of the product “cardiocell” derived from the wharton’s jelly mesenchymal stem cells for treating hindlimb ischemia Musiał-Wysocka A, Kot M, Sułkowski M, Majka M. Int J Mol Sci. 2019 Sep 18;20(18). pii: E4632. doi: 10.3390/ijms20184632.

AFM-based analysis of Wharton’s jelly mesenchymal stem cells. Szydlak R, Majka M, Lekka M, Kot M, Laidler P. Int J Mol Sci. 2019 Sep 5;20(18). pii: E4351. doi: 10.3390/ijms20184351.

The Pros and Cons of Mesenchymal Stem Cell-Based Therapies. Musiał-Wysocka A, Kot M, Majka M.Cell Transplant. 2019 Jul;28(7):801-812. doi: 10.1177/0963689719837897. Epub 2019 Apr 24.

Molecular and functional verification of wharton’s jelly mesenchymal stem cells (WJ-MSCs) pluripotency. Musiał-Wysocka, A., Kot, M., Sułkowski, M., Badyra, B., Majka, M. International Journal of Molecular Sciences. 2019 Apr 12;20(8). pii: E1807. doi: 10.3390/ijms20081807

Mesenchymal Stem Cells as a Salvage Treatment for Severe Refractory Graft-vs-Host Disease in Children After Bone Marrow Transplantation Krasowska-Kwiecien A, Gozdzik J, Jarocha D, Wozniak M, Czogala W, Wiecha O, Skoczen S, Dluzniewska A, Majka M. Transplant Proc. 2019 Apr;51(3):880-889. doi: 10.1016/j.transproceed.2019.01.023. Epub 2019 Jan 8.

C-Met as a Key Factor Responsible for Sustaining Undifferentiated Phenotype and Therapy Resistance in Renal Carcinomas. Marona P, Górka J, Kotlinowski J, Majka M, Jura J, Miekus K. Cells. 2019 Mar 22;8(3). pii: E272. doi: 10.3390/cells8030272.

Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression. Skrzypek K, Kusienicka A, Szewczyk B, Adamus T, Lukasiewicz E, Miekus K, Majka M. Oncotarget. 2015 Oct 13;6(31):31378-98. doi: 10.18632/oncotarget.5145.

Myocardial regeneration strategy using Wharton’s jelly mesenchymal stem cells as an off-the-shelf 'unlimited’ therapeutic agent: results from the Acute Myocardial Infarction First-in-Man Study. Musialek P, Mazurek A, Jarocha D, Tekieli L, Szot W, Kostkiewicz M, Banys RP, Urbanczyk M, Kadzielski A, Trystula M, Kijowski J, Zmudka K, Podolec P, Majka M. Postepy Kardiol Interwencyjnej. 2015;11(2):100-7. doi: 10.5114/pwki.2015.52282. Epub 2015 Jun 22.

MET receptor is a potential therapeutic target in high grade cervical cancer. Miekus K, Pawlowska M, Sekuła M, Drabik G, Madeja Z, Adamek D, Majka M. Oncotarget. 2015 Apr 30;6(12):10086-101.

Continuous improvement after multiple mesenchymal stem cell transplantations in a patient with complete spinal cord injury. Jarocha D, Milczarek O, Wedrychowicz A, Kwiatkowski S, Majka M. Cell Transplant. 2015;24(4):661-72. doi: 10.3727/096368915X687796. Epub 2015 Mar 24.

The strategy of fusion genes construction determines efficient expression of introduced transcription factors. Adamus T, Konieczny P, Sekuła M, Sułkowski M, Majka M. Acta Biochim Pol. 2014;61(4):773-8. Epub 2014 Sep 3.

Efficient myoblast expansion for regenerative medicine use. Jarocha D, Stangel-Wojcikiewicz K, Basta A, Majka M. Int J Mol Med. 2014 Jul;34(1):83-91. doi: 10.3892/ijmm.2014.1763. Epub 2014 Apr 30.

Downregulation of the CXCR4 receptor inhibits cervical carcinoma metastatic behavior in vitro and in vivo. Sekuła M, Miekus K, Majka M. Int J Oncol. 2014 Jun;44(6):1853-60. doi: 10.3892/ijo.2014.2383. Epub 2014 Apr 11.

Preliminary study of autologous bone marrow nucleated cells transplantation in children with spinal cord injury. Jarocha D, Milczarek O, Kawecki Z, Wendrychowicz A, Kwiatkowski S, Majka M. Stem Cells Transl Med. 2014 Mar;3(3):395-404. doi: 10.5966/sctm.2013-0141. Epub 2014 Feb 3.

Autologous muscle-derived cells for the treatment of female stress urinary incontinence: a 2-year follow-up of a Polish investigation. Stangel-Wojcikiewicz K, Jarocha D, Piwowar M, Jach R, Uhl T, Basta A, Majka M. Neurourol Urodyn. 2014 Mar;33(3):324-30. doi: 10.1002/nau.22404. Epub 2013 Apr 19.

The decreased metastatic potential of rhabdomyosarcoma cells obtained through MET receptor downregulation and the induction of differentiation. Miekus K, Lukasiewicz E, Jarocha D, Sekula M, Drabik G, Majka M. Cell Death Dis. 2013 Jan 17;4:e459. doi: 10.1038/cddis.2012.199.

Infarct size determines myocardial uptake of CD34+ cells in the peri-infarct zone: results from a study of (99m)Tc-extametazime-labeled cell visualization integrated with cardiac magnetic resonance infarct imaging. Musialek P, Tekieli L, Kostkiewicz M, Miszalski-Jamka T, Klimeczek P, Mazur W, Szot W, Majka M, Banys RP, Jarocha D, Walter Z, Krupinski M, Pieniazek P, Olszowska M, Zmudka K, Pasowicz M, Kereiakes DJ, Tracz W, Podolec P, Wojakowski W. Circ Cardiovasc Imaging. 2013 Mar 1;6(2):320-8. doi: 10.1161/CIRCIMAGING.112.979633. Epub 2012 Dec 27.

17AEP-GA, an HSP90 antagonist, is a potent inhibitor of glioblastoma cell proliferation, survival, migration and invasion. Miekus K, Kijowski J, Sekuła M, Majka M. Oncol Rep. 2012 Nov;28(5):1903-9. doi: 10.3892/or.2012.1996. Epub 2012 Aug 27.

Mobilization of CD34+CXCR4+ stem/progenitor cells and the parameters of left ventricular function and remodeling in 1-year follow-up of patients with acute myocardial infarction. Wyderka R, Wojakowski W, Jadczyk T, Maślankiewicz K, Parma Z, Pawłowski T, Musiałek P, Majka M, Król M, Kuczmik W, Dworowy S, Korzeniowska B, Ratajczak MZ, Tendera M. Mediators Inflamm. 2012;2012:564027. doi: 10.1155/2012/564027. Epub 2012 Mar 28.

Genetically modified adipose tissue-derived mesenchymal stem cells overexpressing CXCR4 display increased motility, invasiveness, and homing to bone marrow of NOD/SCID mice. Bobis-Wozowicz S, Miekus K, Wybieralska E, Jarocha D, Zawisz A, Madeja Z, Majka M. Exp Hematol. 2011 Jun;39(6):686-696.e4. doi: 10.1016/j.exphem.2011.03.004. Epub 2011 Mar 21.

Randomized transcoronary delivery of CD34(+) cells with perfusion versus stop-flow method in patients with recent myocardial infarction: Early cardiac retention of ⁹⁹(m)Tc-labeled cells activity. Musialek P, Tekieli L, Kostkiewicz M, Majka M, Szot W, Walter Z, Zebzda A, Pieniazek P, Kadzielski A, Banys RP, Olszowska M, Pasowicz M, Zmudka K, Tracz W. J Nucl Cardiol. 2011 Feb;18(1):104-16. doi: 10.1007/s12350-010-9326-z. Epub 2010 Dec 14.

Differential expression of Snail1 transcription factor and Snail1-related genes in alveolar and embryonal rhabdomyosarcoma subtypes. Püsküllüoglu M, Lukasiewicz E, Miekus K, Jarocha D, Majka M. Folia Histochem Cytobiol. 2010 Dec;48(4):671-7. doi: 10.2478/v10042-010-0046-7.